GB
Goodwin Biotechnology, Inc.
About
Single-source biologics CDMO providing end-to-end services from cell line development through fill-finish. Operates new cGMP facility with flexible bioreactor capacity, supports multispecific antibodies, recombinant proteins, vaccines, and cell-based products with comprehensive analytical capabilities.
Services
CDMO